Cargando…

Structural analysis of mitochondrial cytochrome bc(1) complex with atovaquone bound reveals the molecular basis of antimalarial drug action

Detalles Bibliográficos
Autores principales:	Birth, Dominic, Kao, Wei-chun, Hunte, Carola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179283/ http://dx.doi.org/10.1186/1475-2875-13-S1-P103

Ejemplares similares

Molecular basis of extreme resistance in Plasmodium falciparum to atovaquone and other mitochondrial inhibitors
por: Siegel, Sasha, et al.
Publicado: (2014)

Antimalarial pharmacology and therapeutics of atovaquone
por: Nixon, Gemma L., et al.
Publicado: (2013)

Quinone binding sites of cyt bc complexes analysed by X-ray crystallography and cryogenic electron microscopy
por: Kao, Wei-Chun, et al.
Publicado: (2022)

Structure of complex III with bound antimalarial agent CK-2-68 provides insights into selective inhibition of Plasmodium cytochrome bc(1) complexes
por: Esser, Lothar, et al.
Publicado: (2023)

Discovering antimalarials with a differential mode of action
por: Sanz, Laura, et al.
Publicado: (2014)

Targeting the Ubiquinol-Reduction (Q(i)) Site of the Mitochondrial Cytochrome bc(1) Complex for the Development of Next Generation Quinolone Antimalarials
por: Amporndanai, Kangsa, et al.
Publicado: (2022)

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
por: Skinner-Adams, Tina S., et al.
Publicado: (2019)

7-N-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome bc(1) Complex
por: Nguyen, William, et al.
Publicado: (2023)

Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc(1) Catalytic Turnover and Protein Expression
por: Fisher, Nicholas, et al.
Publicado: (2012)

Insights into cytochrome bc (1) complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling
por: Sodero, Ana Carolina Rennó, et al.
Publicado: (2017)

Cytauxzoon felis cytochrome b gene mutation associated with atovaquone and azithromycin treatment
por: Hartley, Ashley N., et al.
Publicado: (2020)

Antimalarial drugs: unexpected evolutionary consequences
por: Schneider, Petra, et al.
Publicado: (2010)

Emergence of cytochrome bc complexes in the context of photosynthesis
por: Dibrova, Daria V., et al.
Publicado: (2017)

Cytochrome P450 modulates the therapeutic actions of tamoxifen, as evidenced in novel breast cancer models
por: Polson, E, et al.
Publicado: (2008)

Dynamic prediction methods in the BC2001 clinical trial
por: Porta, Nuria, et al.
Publicado: (2015)

The role of antimalarials in lupus nephritis: a review
por: Lee, Senq-J, et al.
Publicado: (2012)

X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
por: Amporndanai, Kangsa, et al.
Publicado: (2018)

525. Atovaquone for Treatment of COVID-19 (Ataq COVID-19) Trial
por: Jain, Mamta K, et al.
Publicado: (2021)

A framework for assessing the risk of resistance for antimalarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

Mitochondrial respiration and cytochrome c inhibition by sulfide in peritoneal macrophages in vitro: effects of temperature and pH
por: Groeger, M, et al.
Publicado: (2010)

Phosphatidylethanolamine made in the inner mitochondrial membrane is essential for yeast cytochrome bc(1) complex function
por: Calzada, Elizabeth, et al.
Publicado: (2019)

The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion
por: Yamamoto, Mizuki, et al.
Publicado: (2020)

Aspidosperma species (Apocynaceae) as sources of antimalarials: from the in vitro antiplasmodial activity of extracts to pre-clinical toxicological studies for the development of efficient and safe antimalarial phytomedicines
por: Braga de Oliveira, Alaide, et al.
Publicado: (2014)

Antimalarial treatment by health care providers in Port Harcourt, Nigeria
por: Ebong, Omotavo O, et al.
Publicado: (2012)

Dual mode of action of metformin on mitochondrial metabolism
por: Andrzejewski, Sylvia, et al.
Publicado: (2014)

HIV-1 CRF08_BC mutants resistant to reverse transcriptase inhibitors
por: Wu, Hao, et al.
Publicado: (2014)

Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
por: Yoon, Ho Sup, et al.
Publicado: (2010)

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola
por: Pimentel, Sónia, et al.
Publicado: (2006)

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
por: Fiorillo, Marco, et al.
Publicado: (2016)

Collaborative approaches for Target ID in neglected diseases: identifying new antimalarial targets
por: Lafuente, Maria Jose, et al.
Publicado: (2014)

Feasible study of MRgFUS of early breast cancer - report of completion of BC006 in Japan
por: Namba, Kiyoshi, et al.
Publicado: (2015)

The Molecular Evolution of the Q(o) Motif
por: Kao, Wei-Chun, et al.
Publicado: (2014)

In-vitro studies on the sensitivity pattern of Plasmodium falciparum to antimalarial drugs and local herbal extracts
por: Olasehinde, Grace, et al.
Publicado: (2012)

Structure of yeast cytochrome c oxidase in a supercomplex with cytochrome bc(1)
por: Hartley, Andrew M., et al.
Publicado: (2018)

Modeling the Energy Landscape of Side Reactions in the Cytochrome bc(1) Complex
por: Husen, Peter, et al.
Publicado: (2021)

Differences in the pharmacokinetics of currently approved antimalarial drugs in uncomplicated malaria patients compared to healthy subjects
por: Jain, Jay Prakash, et al.
Publicado: (2012)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
por: Stein, Daniel S, et al.
Publicado: (2014)

Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)

In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand
por: Khositnithikul, Rommanee, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0julbk0soe5u62cfqaj8fdqb4n